Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
Clinical trial NCT04990544 · UNKNOWN
Trial details
- NCT number
- NCT04990544
- Sponsor
- Shanghai Zerun Biotechnology Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2022-04-22
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.